Clinical Trials

94 enrolled

Nasopharyngeal Neoplasms

NCT03082534 2026-01-28

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

78 enrolled

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

NCT05807880 2026-01-23

ALTER-HN005

59 enrolled

Nasopharyngeal Neoplasms

NCT04004871 2025-12-11

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

60 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT07277764 2025-12-11

REDEFINE

23 enrolled

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT04925544 2025-10-21

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

13 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT05305131 2025-09-23

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Phase 2 Enrolling by invitation

Nasopharyngeal Neoplasms

NCT06688175 2025-08-07

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

32 enrolled

Nasopharyngeal Neoplasms

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

208 enrolled

Pathologic Complete Response, Nasopharyngeal Neoplasms

NCT04875611 2025-04-24

NIVONASO-21

32 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Neoplasms

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

150 enrolled

Nasopharyngeal Neoplasms, Recurrence

NCT06349889 2025-01-15

Adebrelimab and Chemoradiotherapy in High-risk LANPC

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT06414577 2024-12-30

Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy

38 enrolled

Nasopharyngeal Neoplasms

NCT06733948 2024-12-13

ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT06611826 2024-09-25

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

41 enrolled

Nasopharyngeal Neoplasms

NCT02875613 2024-08-28

Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer

6 enrolled 8 charts

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT06019130 2024-05-16

NPC-Nivo

57 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT05385926 2024-02-05

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

34 enrolled

Nasopharyngeal Neoplasms

NCT05198479 2023-10-11

SG-AAA-II-01

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT00003206 2023-06-15

Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

Head and Neck Neoplasms, Nasopharyngeal Neoplasms

NCT03180476 2023-04-14

Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma

21 enrolled

Phase 2 Not yet recruiting

Nasopharyngeal Neoplasms

NCT04870905 2023-03-06

Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Neoplasms

NCT05628922 2022-11-29

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

198 enrolled

Nasopharyngeal Neoplasms

NCT04978012 2022-06-07

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

48 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT03854838 2022-04-29

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT02605967 2022-02-10

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

122 enrolled 28 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Recurrence, Disorders of Sex Development

NCT02874651 2022-01-11

ADVANCE

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT05101889 2021-11-01

Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation

110 enrolled

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Stomatitis

NCT03096808 2021-10-26

Adaptive Radiotherapy for Head and Neck Cancer

64 enrolled

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms

NCT01094405 2021-07-28

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Nasopharyngeal Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT03129412 2020-09-17

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

64 enrolled

Nasopharyngeal Neoplasms, Neoplasm Metastasis

NCT04476641 2020-07-20

DC-CIK

BreastGastrointestinalGenitourinaryHead & NeckThoracic

686 enrolled

Breast Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Colorectal Neoplasms

NCT04446663 2020-06-25

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

NCT02444949 2020-06-24

A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma

75 enrolled

Nasopharyngeal Neoplasms

NCT00524017 2020-03-12

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Head & NeckOther neoplasm

35 enrolled 6 charts

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Salivary Gland Neoplasms

NCT00188877 2019-12-02

Intensity Modulated Radiation Therapy for Head and Neck Cancer

44 enrolled

Nasopharyngeal Neoplasms

NCT02339558 2019-09-13

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

45 enrolled 12 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

1 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections

NCT03890185 2019-03-26

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

108 enrolled

Nasopharyngeal Neoplasms

NCT00603915 2019-02-28

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

20 enrolled 8 charts

Nasopharyngeal Neoplasms

NCT02902432 2019-01-31

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

24 enrolled

Nasopharyngeal Neoplasms

NCT02269943 2018-12-12

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

36 enrolled 24 charts

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT03619824 2018-10-09

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

40 enrolled

Nasopharyngeal Neoplasms

NCT00052611 2018-03-29

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

23 enrolled

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT00003489 2017-11-21

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

7 enrolled

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT01762514 2017-07-13

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

360 enrolled

Head & NeckOther

Nasopharyngeal Carcinoma, Bone Marrow Diseases, Nasopharyngeal Neoplasms, Salivary Gland Diseases, Xerostomia, Mucositis

NCT03175939 2017-06-05

Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

263 enrolled

Nasopharyngeal Neoplasms

NCT00376987 2017-05-30

Zinc Supplements in Lowering Cadmium Levels in Smokers

GastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

61 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Tobacco Use Disorder, Tongue Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

NCT00534001 2017-05-30

Bupropion in Helping Adults Stop Smoking